Partnering

INSIGHTS ON CLINICAL TRIAL PARTNERING

Reducing The Travel Burden For Patients - The Benefits Of Mobile Vision Clinics
Travel to trial sites can be a major hurdle for patients considering participation, but mobile vision clinics are providing a solution to improve accessibility, capacity, and patient enrollment.
The Ten Commandments Of Vendor Selection
Selecting the right vendors sets the foundation for efficient operations and reliable outcomes, and these ten essential principles can guide sponsors in making informed vendor choices.
Bridging The Engagement Gap In Obesity Trials
Improve obesity trial retention with actionable guidance: provide proactive plateau counseling, simplify data capture, and leverage existing provider-patient relationships to sustain motivation.
Site Initiation Visits For Clinical Trials: Ocular Endpoint Planning For Sponsors And CROs
Learn how expert site initiation visit (SIV) planning masters complex endpoints like OCT and BCVA, eliminates data variability, and prevents the costly need for trial rescue.

Leading Recruitment With A Strong Alzheimer's Referral Pool
2/24/2026

A strong referral network helped the Gainesville site rapidly recruit pTau217‑positive Alzheimer’s participants while upholding high data quality, boosting enrollment and outperforming other sites.
Optimizing EDC Strategy And Data Collection for a Rare Disease Trial
6/11/2025

Explore how Veristat created a forward-looking roadmap for EDC and CRFs integration for a small biotech sponsor, ensuring a future-ready data ecosystem without overcomplicating current operations.
The State Of Materiovigilance: Capability Gaps, Technology Momentum, And Outsourcing Readiness
5/12/2026

Explore how pharma and biotech companies are using AI, outsourcing, and new technologies to strengthen materiovigilance for complex drug-device products.
Multi-Site Capabilities For Your Phase I-II Trials
5/1/2026

Master the complexities of renal and hepatic trials by leveraging site expertise and PK modeling to navigate recruitment challenges and ensure precise dosing for impaired patient populations.
Mastering The Complexities Of Gene Therapy Document Writing
5/20/2025

Gain the insight and strategic flexibility needed to confidently navigate the unique scientific, regulatory, and documentation challenges of gene therapy development.

Your Partners In Drug Development And Safety

How can Ergomed use its oncology expertise, global reach, and access to patients with rare and ultra-rare diseases can help your organization achieve efficient, high-quality clinical trial execution?
Study Start-Up Shouldn't Slow Your Trials Down

Clinical teams are responsible for driving trial timelines during the study start-up phase of any study. Unearth how Florence SiteLink is able to create a digital link between teams and their sites.
Accelerate Your Clinical Trials In Australia

Accelerate your biotech trials in Australia—cut costs by up to 60%, enroll patients in as little as 4–6 weeks, and generate FDA- and EMA-accepted data with no IND required.
Accelerating FIH Trials To POC With Speed, Safety, And Certainty

Overcome clinical transition challenges with integrated services, including study design, expert regulatory support, robust recruitment, and flexible manufacturing.
Advancing Development And Approval Of Rare/Ultra-Rare Disease Therapies

Veristat empowers rare disease therapy with science-driven strategies and trusted expertise, supporting over 350 rare disease projects and preparing 40+ marketing applications in the past five years.